27,28 When converting between glargine and detemir, it has been found that the conversion is not one-to-one as previously thought
Waldstein lists seven possible areas where claims can be made: Promotes satiety and lessens food noise Supports energy Supports balanced blood sugar levels already within normal range Supports cognition and mood Helps support a persons weight loss journey Helps an individual feel their best Supports muscle mass integrity Supporting the GLP-1 journey Since the influx of weight-loss-inducing GLP-1 agonist medications (think brands like Ozempic, Wegovy and Mounjaro), supplement companies have rolled out products to support consumers on their health journeys, marketing supplements like fiber, probiotics and herbal extracts to combat the side effects of GLP-1s

Research examining human cardiac samples has revealed several key findings: GLP-1R mRNA transcripts have been consistently detected in all four cardiac chambers from human hearts, at levels approximating those in human pancreas [1] Receptor expression is notably absent in cardiac fibroblasts, coronary artery endothelial cells, and vascular smooth muscle cells according to some studies [1] Human GLP-1R expression appears predominantly in cardiomyocytes, albeit at relatively low levels [2] Interestingly, species differences exist in GLP-1R distribution patterns
Mounjaro and Zepbound are branded, FDA-approved medications
To put that into perspective, someone who started the trial at 300 pounds could theoretically lose about 60 pounds on tirzepatide versus roughly 41 pounds on semaglutide over about a year and four months
One moment, please